People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Odyssey Thera Inc. | — | Biotechnology | Seed | $3.5M | $155.4M | 2010 |
| Vala Sciences Inc. | — | Biotechnology | Seed | $2.0M | $88.7M | 2015 |
| AskY Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $740K | $2.3M | 2024 |
John Westwick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Westwick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dan Watkins | 1 | 8 |
| Bryant Fong | 1 | 5 |
| Mark McWilliams | 1 | 4 |
| David U'Prichard | 1 | 4 |
| Jeffrey Price | 1 | 3 |
| Alexander Krupnick | 1 | 2 |
| Hugh Reinhoff | 1 | 1 |
| Terry Meador | 1 | 1 |
| Michael Geremia | 1 | 1 |
| Alan Sachs | 1 | 1 |
| Thomas Caskey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.